Skip to main content

Advertisement

Log in

Association of vitamin D status and blood pressure response after renal denervation

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Vitamin D deficiency is associated with hypertension; however, it is unclear whether vitamin D influences therapeutic blood pressure reduction. Renal sympathetic denervation (RDN) reduces blood pressure in resistant hypertension. We hypothesized that vitamin D might influence blood pressure response to RDN.

Methods

Vitamin D was measured in 101 patients with resistant hypertension undergoing RDN. The associations between vitamin D status and systolic blood pressure (SBP) reduction 6 months after RDN were analyzed.

Results

Mean office SBP at baseline was 171.5 ± 2 mmHg. After RDN, mean office SBP was reduced by 28.4 ± 2.3 mmHg (p = 0.007). 85 patients (84.2 %) had SBP reductions >10 mmHg (responders). Vitamin D concentrations were lower in non-responders as compared to responders (9.9 ± 4.5 vs. 13.7 ± 7.4 ng/ml, p = 0.008). Non-responders (n = 16, 15.8 %), more often had a vitamin D concentration below the median as compared to responders (81 vs. 46 %, p = 0.013). The percentage of patients with normal vitamin D concentrations increased with increasing tertiles of SBP reduction (p for trend = 0.020). In patients with vitamin D concentrations below the median, SBP reduction was lower as compared to patients with a vitamin D concentration above the median (23.5 ± 3.2 vs. 33.7 ± 3.2 mmHg, p = 0.026). Baseline vitamin D concentrations correlated with SBP reduction (r = 0.202, p = 0.043).

Conclusions

In patients with resistant hypertension, low vitamin D concentrations were associated with a decreased SBP response and a higher rate of non-response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF (2008) Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52(24):1949–1956

    Article  CAS  PubMed  Google Scholar 

  2. Lavie CJ, Lee JH, Milani RV (2011) Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 58(15):1547–1556

    Article  CAS  PubMed  Google Scholar 

  3. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT (2011) Vitamin D status: United States, 2001–2006. NCHS Data Brief 59:1–8

    PubMed  Google Scholar 

  4. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167(11):1159–1165

    Article  CAS  PubMed  Google Scholar 

  5. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503–511

    Article  CAS  PubMed  Google Scholar 

  6. Kristal-Boneh E, Froom P, Harari G, Ribak J (1997) Association of calcitriol and blood pressure in normotensive men. Hypertension 30(5):1289–1294

    Article  CAS  PubMed  Google Scholar 

  7. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8(9):894–901

    Article  CAS  PubMed  Google Scholar 

  8. DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75–197

    CAS  PubMed  Google Scholar 

  9. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903–1909

    Article  PubMed  Google Scholar 

  10. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281

    Article  PubMed  Google Scholar 

  11. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H (2011) Sympatho-renal axis in chronic disease. Clin Res Cardiol 100(12):1049–1057

    Article  PubMed Central  PubMed  Google Scholar 

  12. Mahfoud F, Himmel F, Ukena C, Schunkert H, Böhm M, Weil J (2011) Treatment strategies for resistant arterial hypertension. Dtsch Arztebl Int 108(43):725–731

    PubMed Central  PubMed  Google Scholar 

  13. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123(2):209–215

    Article  PubMed  Google Scholar 

  14. Ukena C, Mahfoud F, Kindermann I, Barth C, Lenski M, Kindermann M, Brandt MC, Hoppe UC, Krum H, Esler M, Sobotka PA, Böhm M (2011) Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 58(11):1176–1182

    Article  PubMed  Google Scholar 

  15. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123(18):1940–1946

    Article  CAS  PubMed  Google Scholar 

  16. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101(1):63–67

    Article  PubMed  Google Scholar 

  17. Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Kramer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC, Arbeitsgemeinschaft Herz und Niere der Deutschen Gesellschaftfur Kardiologie–Herz–und Kreislaufforschunge VudDGfNVsdDHeVDH (2011) Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment. Dtsch Med Wochenschr 136 (47):2418

    Google Scholar 

  18. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Collection: Reports funded by National Institutes of Health, Washington

  19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19):2560–2572

    Article  CAS  PubMed  Google Scholar 

  20. Scragg R, Sowers M, Bell C (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20(7):713–719

    Article  CAS  PubMed  Google Scholar 

  21. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49(5):1063–1069

    Article  CAS  PubMed  Google Scholar 

  22. Merke J, Milde P, Lewicka S, Hugel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E (1989) Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83(6):1903–1915

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353–373

    Article  CAS  PubMed  Google Scholar 

  24. Merke J, Hofmann W, Goldschmidt D, Ritz E (1987) Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 41(2):112–114

    Article  CAS  PubMed  Google Scholar 

  25. McGreevy C, Williams D (2011) New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 155(12):820–826

    Article  PubMed  Google Scholar 

  26. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110(2):229–238

    CAS  PubMed Central  PubMed  Google Scholar 

  27. Qiao G, Kong J, Uskokovic M, Li YC (2005) Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis. J Steroid Biochem Mol Biol 96(1):59–66

    Article  CAS  PubMed  Google Scholar 

  28. Resnick LM, Muller FB, Laragh JH (1986) Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 105(5):649–654

    Article  CAS  PubMed  Google Scholar 

  29. Carthy EP, Yamashita W, Hsu A, Ooi BS (1989) 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13(6 Pt 2):954–959

    Article  CAS  PubMed  Google Scholar 

  30. Borges AC, Feres T, Vianna LM, Paiva TB (1999) Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34(4 Pt 2):897–901

    Article  CAS  PubMed  Google Scholar 

  31. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25(3):320–325

    Article  CAS  PubMed  Google Scholar 

  32. Dong J, Wong SL, Lau CW, Lee HK, Ng CF, Zhang L, Yao X, Chen ZY, Vanhoutte PM, Huang Y (2012) Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J 33(23):2980–2990

    Article  CAS  PubMed  Google Scholar 

  33. Intersalt Cooperative Research Group (1988) Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 297(6644):319–328

    Article  Google Scholar 

  34. Woodhouse PR, Khaw KT, Plummer M (1993) Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens 11(11):1267–1274

    Article  CAS  PubMed  Google Scholar 

  35. Jorde R, Bonaa KH (2000) Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study. Am J Clin Nutr 71(6):1530–1535

    CAS  PubMed  Google Scholar 

  36. Sowers MR, Wallace RB, Lemke JH (1985) The association of intakes of vitamin D and calcium with blood pressure among women. Am J Clin Nutr 42(1):135–142

    CAS  PubMed  Google Scholar 

  37. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86(4):1633–1637

    Article  CAS  PubMed  Google Scholar 

  38. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM (2010) Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152(5):307–314

    Article  PubMed Central  PubMed  Google Scholar 

  39. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307(7):674–684

    Article  CAS  PubMed  Google Scholar 

  40. Symplicity HTNI (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57(5):911–917

    Article  Google Scholar 

Download references

Acknowledgments

FM, CU and MB are supported by the Ministry of Science and Economy of the Saarland. FM is supported by the Deutsche Hochdruckliga. FM and MB are supported by the Deutsche Forschungsgemeinschaft (KFO 196). MS is supported by an NHMRC Senior Research Fellowship.

Conflict of interest

All authors received scientific support from Medtronic Ardian Inc. FM, BC, CU, MS, ME, UL, and MB received speaker honorarium from Medtronic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janine Pöss.

Additional information

J. Pöss and F. Mahfoud contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pöss, J., Mahfoud, F., Ukena, C. et al. Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol 103, 41–47 (2014). https://doi.org/10.1007/s00392-013-0621-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-013-0621-y

Keywords

Navigation